olmesartan medoxomil
- RxCUI
- 118463
- RxNorm name
- olmesartan medoxomil
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-24 12:44:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| olmesartan | 321064 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 9d9f1c08-4f65-484c-943e-7e664281910f | 2023-09-12 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 5f410909-a68a-4ada-963a-32018d37572f | 2023-09-11 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 949e6bad-fcb2-42f2-b9c8-e5620ef5ccd5 | 2023-08-28 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Benicar | OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | 5b6f8a18-8f8a-4521-81c3-3a39c73c6646 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Alembic Pharmaceuticals Inc. | cf4f62f9-5a00-4313-b703-ec0ac6380b5e | 2023-06-23 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 409e06ad-2ea9-4b47-829e-57139e22eac9 | 2023-06-05 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 7afa79de-d42e-4429-874d-449d47a59fbe | 2023-05-25 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Alembic Pharmaceuticals Limited | ac08ea7d-f529-42ca-850a-a0ecce7dc830 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Solco Healthcare US, LLC. | 6e602f81-1cc3-4ae1-8bdf-85572e35cf73 | 2022-03-04 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | ScieGen Pharmaceuticals, Inc. | f15664a4-6b5f-4e88-ad56-c827ed90a40c | 2021-01-08 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Proficient Rx LP | e210f962-9b91-46c6-af8f-9f9a9ae84245 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09CA | Angiotensin II receptor blockers (ARBs), plain | ATC1-4 | olmesartan medoxomil | |
| FDASPL | N0000175561 | Angiotensin 2 Receptor Blocker | EPC | has_epc | olmesartan |
| FDASPL | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | D007093 | Imidazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000068557 | Olmesartan Medoxomil | CHEM | has_ingredient | olmesartan medoxomil |
| MEDRT | D013777 | Tetrazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan medoxomil |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan medoxomil |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | ATC | C09CA08 |
| CODES | SNOMEDCT | 412260006 |
| CODES | USP | m887 |
| CODES | VUID | 4021345 |
| SOURCES | Source | Anatomical Therapeutic Chemical |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |